1. Home
  2. ATHA vs TMDE Comparison

ATHA vs TMDE Comparison

Compare ATHA & TMDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Athira Pharma Inc.

ATHA

Athira Pharma Inc.

HOLD

Current Price

$6.91

Market Cap

26.0M

Sector

Health Care

ML Signal

HOLD

TMDE

TMD Energy Limited Ordinary Shares

HOLD

Current Price

$0.94

Market Cap

14.6M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATHA
TMDE
Founded
2011
2016
Country
United States
Malaysia
Employees
26
N/A
Industry
Medicinal Chemicals and Botanical Products
Oil Refining/Marketing
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
26.0M
14.6M
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
ATHA
TMDE
Price
$6.91
$0.94
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.2M
5.9M
Earning Date
02-26-2026
09-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$607,422,733.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.20
$0.41
52 Week High
$8.36
$6.27

Technical Indicators

Market Signals
Indicator
ATHA
TMDE
Relative Strength Index (RSI) 62.50 63.89
Support Level $6.41 $0.42
Resistance Level $7.64 $1.39
Average True Range (ATR) 0.69 0.12
MACD 0.03 0.04
Stochastic Oscillator 68.86 54.08

Price Performance

Historical Comparison
ATHA
TMDE

About ATHA Athira Pharma Inc.

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.

About TMDE TMD Energy Limited Ordinary Shares

TMD Energy Ltd is engaged in marine fuel bunkering services specializing in the supply and marketing of marine gas oil and marine fuel oil (including high sulfur fuel oil, low sulfur fuel oil and very low sulfur fuel oil), to ships and vessels at sea. It is also involved in the provision of ship management services for in-house and external vessels, as well as vessel chartering. It is currently operating with a fleet of nearly 15 bunkering vessels ranging from 540 dwt to 7,820 dwt, of which nearly nine (9) are double bottom and double hull vessels with an average cargo-carrying capacity of approximately 4,200 dwt each.

Share on Social Networks: